These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37005486)

  • 21. Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses.
    Holowko N; Eriksson M; Kuja-Halkola R; Azam S; He W; Hall P; Czene K
    Cancer Res; 2020 Apr; 80(7):1590-1600. PubMed ID: 32241951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated With False-Positive Recalls in Mammography Screening.
    Mao X; He W; Humphreys K; Eriksson M; Holowko N; Strand F; Hall P; Czene K
    J Natl Compr Canc Netw; 2023 Feb; 21(2):143-152.e4. PubMed ID: 36791753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
    Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
    Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Petersen K; Lillholm M; Nielsen MB; Lynge E; Uldall WY; Vejborg I
    BMC Cancer; 2016 Jul; 16():414. PubMed ID: 27387546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening.
    Mital S; Nguyen HV
    BMC Cancer; 2022 May; 22(1):501. PubMed ID: 35524200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting.
    McWilliams L; Evans DG; Payne K; Harrison F; Howell A; Howell SJ; French DP;
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
    Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
    Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of personalized screening and prevention recommendations in the general population through breast cancer risk assessment: results from a dedicated risk clinic.
    Saghatchian M; Abehsera M; Yamgnane A; Geyl C; Gauthier E; Hélin V; Bazire M; Villoing-Gaudé L; Reyes C; Gentien D; Golmard L; Stoppa-Lyonnet D
    Breast Cancer Res Treat; 2022 Apr; 192(2):375-383. PubMed ID: 34994879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.
    Weisstock CR; Rajapakshe R; Bitgood C; McAvoy S; Gordon PB; Coldman AJ; Parker BA; Wilson C
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1084-92. PubMed ID: 23963801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
    Atakpa EC; Thorat MA; Cuzick J; Brentnall AR
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort.
    Vierkant RA; Degnim AC; Radisky DC; Visscher DW; Heinzen EP; Frank RD; Winham SJ; Frost MH; Scott CG; Jensen MR; Ghosh K; Manduca A; Brandt KR; Whaley DH; Hartmann LC; Vachon CM
    BMC Cancer; 2017 Jan; 17(1):84. PubMed ID: 28143431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Women at High Risk for Breast Cancer.
    Yogendran L; Meis L; Burnside E; Schrager S
    J Am Board Fam Med; 2024 Jan; 36(6):1029-1032. PubMed ID: 37857439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
    Moss S
    J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventative therapy for breast cancer: a clinical experience.
    Law R; Krupa K; Rusby J
    Breast Cancer Res Treat; 2023 Sep; 201(2):205-213. PubMed ID: 37336835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.
    Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW
    Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer.
    Duffy SW; Morrish OWE; Allgood PC; Black R; Gillan MGC; Willsher P; Cooke J; Duncan KA; Michell MJ; Dobson HM; Maroni R; Lim YY; Purushothaman HN; Suaris T; Astley SM; Young KC; Tucker L; Gilbert FJ
    Eur J Cancer; 2018 Jan; 88():48-56. PubMed ID: 29190506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?
    McWilliams L; Woof VG; Donnelly LS; Howell A; Evans DG; French DP
    BMC Cancer; 2021 May; 21(1):637. PubMed ID: 34051753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.
    Brentnall AR; Cohn WF; Knaus WA; Yaffe MJ; Cuzick J; Harvey JA
    J Breast Imaging; 2019 Jun; 1(2):99-106. PubMed ID: 31423486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammographic density and breast cancer screening.
    Bell RJ
    Climacteric; 2020 Oct; 23(5):460-465. PubMed ID: 32643449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.